Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening

By MedImaging International staff writers
Posted on 17 Jan 2024
Image: The Lunit INSIGHT CXR AI-powered chest X-ray analysis solution (Photo courtesy of Lunit)
Image: The Lunit INSIGHT CXR AI-powered chest X-ray analysis solution (Photo courtesy of Lunit)

Samsung Healthcare (Suwon, South Korea) and Lunit (Seoul, South Korea) have entered into a collaboration to integrate Lunit's AI technology into Samsung's premium X-ray devices, enhancing the accuracy and speed of chest screening.

Under the terms of the three-year supply contract, Lunit will provide two AI-powered chest screening solutions: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to Samsung. INSIGHT CXR is an AI-powered chest X-ray analysis solution with the capability to detect 10 of the most common lung abnormalities, including lung cancer, pneumonia, and pneumothorax. INSIGHT CXR Triage is an FDA-cleared AI solution that can identify pre-specified critical findings, such as pleural effusion or pneumothorax, on frontal chest X-ray images. The software then flags the images in the Picture Archiving and Communication System (PACS) workstation, enabling a prioritized review process for timely intervention.

Given the urgency of cases generally experienced in Intensive Care Units (ICUs) and Emergency Rooms (ERs), Samsung’s X-ray devices with the Lunit INSIGHT CXR Triage will be mainly deployed in these high-stakes medical settings. During the initial phase of this collaboration, Samsung’s X-ray devices integrated with Lunit's AI solutions will target markets in the US, Canada, and Europe. In the future, the availability of these devices will be expanded to the Middle East, South America, and Southeast Asia, thus broadening their global reach.

"The synergy between Lunit and Samsung Electronics will enable faster, more accurate chest screenings, leading to timely interventions and improved patient outcomes," said Brandon Suh, CEO of Lunit. “We're excited about the potential this partnership holds for advancing chest X-ray practices, particularly in ICUs and ERs.”

Related Links:
Samsung Healthcare
Lunit 

Half Apron
Demi
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
X-Ray Illuminator
X-Ray Viewbox Illuminators
Biopsy Software
Affirm® Contrast

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.